About Sanofi-Aventis Administrative Office
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Sanofi-Aventis Administrative Office
During the past decade, Sanofi-Aventis Administrative Office conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery
2015-11-06
2029-01-01
Recruiting
126
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
2017-01-13
2023-10-31
Active, not recruiting
818
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2017-05-12
2023-06-30
Active, not recruiting
444
Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes
2017-09-29
2022-04-15
Terminated
23
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
2017-12-22
2023-08-01
Active, not recruiting
1,670
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
2017-06-01
2024-08-01
Suspended
310
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
2017-04-13
2023-11-30
Suspended
175
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Sanofi-Aventis Administrative Office"
#1 collaborator was "Bristol-Myers Squibb" with 6 trials as a collaborator, "Cancer International Research Group (CIRG)" with 3 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Population Health Research Institute" with 1 trials as a collaborator and "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Sanofi-Aventis Administrative Office
According to Clinical.Site data, the most researched conditions in "Sanofi-Aventis Administrative Office" are
"Hygiene" (49 trials), "Healthy" (8 trials), "Diabetes Mellitus, Type 2" (5 trials), "Atrial Fibrillation" (4 trials) and "Breast Neoplasms" (3 trials). Many other conditions were trialed in "Sanofi-Aventis Administrative Office" in a lesser frequency.
Clinical Trials Intervention Types at Sanofi-Aventis Administrative Office
Most popular intervention types in "Sanofi-Aventis Administrative Office" are "Drug" (119 trials), "Device" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "LACTIC ACID(ND)" (15 trials), "Lactic acid (Dermacid)" (12 trials), "Placebo" (9 trials), "placebo" (8 trials) and "Lactic Acid" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Sanofi-Aventis Administrative Office
The vast majority of trials in "Sanofi-Aventis Administrative Office" are
68 trials for "All" genders, 49 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Sanofi-Aventis Administrative Office
Currently, there are NaN active trials in "Sanofi-Aventis Administrative Office".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 106 completed trials in Sanofi-Aventis Administrative Office,
undefined suspended trials,
and 14 terminated clinical trials to date.
Out of the total trials that were conducted in Sanofi-Aventis Administrative Office, 0 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 98 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 16 trials, and there were
also 0 trials that are defined as “Not Applicable".